Your browser doesn't support javascript.
loading
Efficacy and safety of drugs for people with type 2 diabetes mellitus and chronic kidney disease on kidney and cardiovascular outcomes: A systematic review and network meta-analysis of randomized controlled trials.
Yang, Qing; Lang, Yanlin; Yang, Wenjie; Yang, Fenghao; Yang, Jia; Wu, Yucheng; Xiao, Xiang; Qin, Chunmei; Zou, Yutong; Zhao, Yuancheng; Kang, Deying; Liu, Fang.
Afiliación
  • Yang Q; Division of Nephrology, West China Hospital of Sichuan University, Chengdu, China; Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, China.
  • Lang Y; Division of Nephrology, West China Hospital of Sichuan University, Chengdu, China; Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, China.
  • Yang W; Division of Project Design and Statistics, West China Hospital of Sichuan University, Chengdu, China.
  • Yang F; Department of Clinical Medicine, Southwest Medical University, Luzhou, China.
  • Yang J; Division of Nephrology, West China Hospital of Sichuan University, Chengdu, China; Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, China.
  • Wu Y; Division of Nephrology, West China Hospital of Sichuan University, Chengdu, China; Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, China.
  • Xiao X; Division of Nephrology, West China Hospital of Sichuan University, Chengdu, China; Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, China.
  • Qin C; Division of Nephrology, West China Hospital of Sichuan University, Chengdu, China; Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, China.
  • Zou Y; Division of Nephrology, West China Hospital of Sichuan University, Chengdu, China; Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, China.
  • Zhao Y; Division of Nephrology, West China Hospital of Sichuan University, Chengdu, China; Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, China.
  • Kang D; Division of Project Design and Statistics, West China Hospital of Sichuan University, Chengdu, China.
  • Liu F; Division of Nephrology, West China Hospital of Sichuan University, Chengdu, China; Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, China. Electronic address: liufangfh@163.com.
Diabetes Res Clin Pract ; 198: 110592, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36842477

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Hiperpotasemia Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Diabetes Res Clin Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Hiperpotasemia Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Diabetes Res Clin Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Irlanda